VETO Stock | | | EUR 79.00 0.30 0.38% |
Director
Mr. Regis Vimal du Monteil has served as Group Director Finance and Legal Affairs and Member of the Executive Committee of Vetoquinol SA since November 30, 2010. He is a graduate of Ecole de Management de Grenoble . He was appointed by PriceWaterhouseCooper in 1987 as Auditor in Morocco and Lyon, he joined the Nortel Networks Group in 1994. He was appointed Financial Director to Pure Fishing in 2001, then Global Market Director in a familyowned concern. since 2010.
Age | 58 |
Tenure | 14 years |
Phone | 33 3 84 62 55 55 |
Web | https://www.vetoquinol.com |
Vetoquinol Management Efficiency
The company has return on total asset
(ROA) of
0.0774 % which means that it generated a profit of $0.0774 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.11 %, meaning that it generated $0.11 on every $100 dollars invested by stockholders. Vetoquinol's management efficiency ratios could be used to measure how well Vetoquinol manages its routine affairs as well as how well it operates its assets and liabilities.
Vetoquinol has accumulated 7.07
M in total debt with debt to equity ratio
(D/E) of 1.8, which is about average as compared to similar companies. Vetoquinol has a current ratio of 3.19, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Vetoquinol until it has trouble settling it off, either with new capital or with free cash flow. So, Vetoquinol's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vetoquinol sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vetoquinol to invest in growth at high rates of return. When we think about Vetoquinol's use of debt, we should always consider it together with cash and equity.
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. Vetoquinol SA was founded in 1933 and is headquartered in Lure, France. Vetoquinol operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 2004 people. Vetoquinol (VETO) is traded on Euronext Paris in France and employs 2,621 people.
Management Performance
Vetoquinol Leadership Team
Elected by the shareholders, the Vetoquinol's board of directors comprises two types of representatives: Vetoquinol inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vetoquinol. The board's role is to monitor Vetoquinol's management team and ensure that shareholders' interests are well served. Vetoquinol's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vetoquinol's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Matthieu Frechin, CEO, Director and Member of Strategy Committee | |
| Hans Hollegien, Member of the Executive Committee, Group Director - Marketing and Communication | |
| Philippe Gruet, Chief Officer | |
| Isabelle ProustCabrera, Member of the Executive Committee, Group Director - Human Resources | |
| Xavier Berthet, Director Communications | |
| Laurent Thore, Legal Partnerships | |
| Dominique Derveaux, Member of the Executive Committee, Group Director - Europe | |
| Regis Monteil, Group Director of Fin. and Legal | |
| Sandrine Perrier, Chief Officer | |
| Alain Masson, COO and Chief Pharmacist | |
Vetoquinol Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Vetoquinol a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Vetoquinol Stock
Vetoquinol financial ratios help investors to determine whether Vetoquinol Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vetoquinol with respect to the benefits of owning Vetoquinol security.